However, PD-L1 has the opposite effect when it exceeds a certain threshold; aromatic hydrocarbon receptor-induced PD-L1 overexpression in NSCLC reduces the efficacy of anti-PD-1 [17]. The gene discussed is CD274; the disease is non-small cell lung carcinoma.